NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; an ultrasound system that provides enhanced image quality, usability, and convenience for ultrasound professionals. The V8, which recently garnered U.S. FDA clearance, includes two new artificial intelligence (AI) functions: NerveTrack, an AI technology that detects the location of nerves during live scanning; and UterineAssist, which detects tissue changes and assists the user with measurements of the uterus.

“We are pleased to launch the V8. We designed it with the user in mind, from its premium imaging engine to its ergonomic design,” says David Legg, vice president, ultrasound and digital radiography of NeuroLogica. “The ‘V’ in ‘V8’ stands for ‘versatile’ because a wide range of departments from obstetrics to radiology and orthopedics to cardiology can make use of its complex functions. We anticipate the V8 to become a flagship product within the high-end ultrasound category.”

Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of beamforming (CrystalBeam), image processing (CrystalLive), and advanced S-Vue Single Crystal Transducers. Moreover, the V8 is equipped with technologies such as:

  • ShadowHDR: Designed to suppress shadows and enhance the clarity of displayed grayscale images.
  • S-Shearwave Imaging: Provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity.
  • S-Fusion technology: Allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI, which are instantly reconstructed in the corresponding plane.
  • MV-Flow: Enhances the visualization of low-flow blood flow states.

The V8 also has various 3D, 4D, and 5D technologies that allow the user to view anatomy with exceptional detail. Finally, one tool, 5D CNS+, simplifies fetal brain assessment by automatically providing nine planes simultaneously with biometric measurements.